Bml Capital Management
$175M 13F equity value
16 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Bml Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ACRS | ACLARIS THERAPEUTICS INC | 11,975,000 | $63M | 36.2% |
| AVIR | ATEA PHARMACEUTICALS INC | 6,952,330 | $32M | 18.5% |
| ENGN | ENGENE THERAPEUTICS INC | 6,669,908 | $12M | 6.6% |
| KHC | KRAFT HEINZ CO | 465,000 | $11M | 6.3% |
| OM | OUTSET MED INC | 2,519,701 | $11M | 6.2% |
| KMX | CARMAX INC | 172,500 | $9M | 5.2% |
| TLYS | TILLYS INC | 2,150,000 | $9M | 5.2% |
| PMVP | PMV PHARMACEUTICALS INC | 5,330,000 | $7M | 4.1% |
| TIL | INSTIL BIO INC | 645,600 | $5M | 2.8% |
| TGT | TARGET CORP | 37,500 | $5M | 2.8% |
Track Bml Capital Management's 13F portfolio: $175M in reported holdings, 16 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}